Mitali
Mitali Aon, Princeton Junction, NJ US
Patent application number | Description | Published |
---|---|---|
20110208128 | Safety Drug Delivery Connectors - Drug delivery connectors are provided for permitting and blocking fluid flow between a container and a catheter connector or other drug delivery site. Embodiments of the drug delivery connectors include a ball valve for forming a releasable seal within the drug delivery connectors. In one or more embodiments, the ball valve prevents fluid flow between an open proximal end and an open distal end of the drug delivery connector and is movable in a proximal direction to release the releasable seal to permit fluid flow from the open proximal direction to the open distal direction. Methods of delivering medication to a catheter connector that includes an actuator are also provided | 08-25-2011 |
20110208160 | Safety Drug Delivery System - Drug delivery systems are provided that include an actuator assembly permanently attached to a filter for connection of a container containing medications such as epidural anesthesia, to a delivery site. In one or more embodiments, the actuator assembly includes a projection with an opening extending from a distal end of the actuator assembly in a proximal direction and the filter includes an inlet and an outlet in fluid communication with the opening. The filter includes a housing including two plates joined together or a cylindrical body defining a cavity containing filter materials. A conduit may be attached to the outlet of the filter to allow connection of the drug delivery systems described to a delivery site, such as a catheter. Methods of administering a medication to a delivery site are also provided. | 08-25-2011 |
20130018325 | FLANGE EXTENDER FOR USE WITH AN INJECTION DEVICE AND METHOD OF ASSEMBLYAANM Schiller; EricAACI WestfieldAAST NJAACO USAAGP Schiller; Eric Westfield NJ USAANM Laskar; Christina JoyAACI Cliffside ParkAAST NJAACO USAAGP Laskar; Christina Joy Cliffside Park NJ USAANM Aon; MitaliAACI Princeton JunctionAAST NJAACO USAAGP Aon; Mitali Princeton Junction NJ USAANM Caizza; RichardAACI VernonAAST NJAACO USAAGP Caizza; Richard Vernon NJ USAANM Bell; JonAACI WaldwickAAST NJAACO USAAGP Bell; Jon Waldwick NJ US - A flange extender for use with an injection device is described. The flange extender includes first and second flange extender pieces and a locking mechanism to lock the first and second flange extender pieces to one another. In one embodiment, the locking mechanism includes each piece having a locking finger extending from the piece and an aperture adapted to receive the locking finger. The first and second flange extender pieces extend in a direction transverse to a main axis of the injection device to thereby provide a surface area for manual manipulation of the injection device during an injection. The first and second flange extender pieces also attach to each other on opposite sides of the injection device. | 01-17-2013 |
20150157848 | Safety Drug Delivery Connectors - Drug delivery connectors are provided for permitting and blocking fluid flow between a container and a catheter connector or other drug delivery site. Embodiments of the drug delivery connectors include a ball valve for forming a releasable seal within the drug delivery connectors. In one or more embodiments, the ball valve prevents fluid flow between an open proximal end and an open distal end of the drug delivery connector and is movable in a proximal direction to release the releasable seal to permit fluid flow from the open proximal direction to the open distal direction. Methods of delivering medication to a catheter connector that includes an actuator are also provided | 06-11-2015 |
Mitali Mukerji, New Delhi IN
Patent application number | Description | Published |
---|---|---|
20140030709 | Biomarker for Detecting High-Altitude Adaptation and High-Altitude Pulmonary Edema - Present invention relates to the Biomarkers for detecting high altitude adaptation and hypoxia responsiveness and the method thereof. The invention specifically relates to the Gene variants SNPIDs rs479200 and rs480902 in the first intron of EGLN1 (Prolyl Hydroxylase 2) gene as biomarkers for adaptation to high altitude and predisposition for high altitude pulmonary edema and hypoxia responsiveness using a novel integrative approach of phenotyping concepts of Ayurveda with population genetics, and disease genomics. More specifically, the C allele of SNP ID rs480902 and T allele of rs479200 of EGLN1 gene is more frequent in patients of HAPE and nearly absent in native highlanders. The present invention also provides primers and methods suitable for the detection of these allelic variants for the prediction of individual's adaptability to high altitude and hypoxia and/or the genetic analysis of the EGLN1 gene in a population. | 01-30-2014 |
Mitali Samaddar, Andhra Pradesh IN
Patent application number | Description | Published |
---|---|---|
20080268503 | Method for Achieving High-Level Expression of Recombinant Human Interleukin-2 Upon Destabilization of the Rna Secondary Structure - The present invention provides a method for achieving high-level expression of the therapeutically important lymphokine (human IL-2). The method comprises of identifying the secondary structure in the 5′ region of human IL-2 mRNA, modifying the 5′ region of the human IL-2 DNA sequence to produce a new DNA sequence wherein the mRNA transcribed from the modified human IL-2 DNA sequence has the predicted 5′ secondary structure destabilized with increased free energy compared to that of the secondary structure of the mRNA transcribed from the native DNA sequence without altering the sequence of the encoded amino acids; and using this modified DNA sequence of human IL-2 for high level recombinant expression in a microbial host for large scale production. This method is also applicable to other expression host like yeasts and mammalian cells. | 10-30-2008 |
Mitali Samaddar, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20150210737 | INTEGRATED PROCESS FOR THE PRODUCTION OF THERAPEUTICS (HUMAN ALBUMIN, INTRAVENOUS IMMUNOGLOBULINS, CLOTTING FACTOR VIII AND CLOTTING FACTOR IX) FROM HUMAN PLASMA - The invention relates to an integrated scheme for fractionation and purification of plasma products (human albumin, intravenous immunoglobulin (IVIG), clotting factor VIII and clotting factor IX) by sequential chromatography and virus reduction steps. The therapeutically administrable protein IVIG has purity levels exceeding 98%, aggregates and dimers at less than 0.2%, Fc function of >90% and anti-complementary activity of less than 0.5 CH | 07-30-2015 |
Mitali Sarkar-Tyson, Wiltshire GB
Patent application number | Description | Published |
---|---|---|
20100062022 | IMMUNOGENIC PROTEINS OF BURKHOLDERIA PSEUDOMALLEI AND USES THEREOF - A protein derived from an outer layer of | 03-11-2010 |
Mitali Sarkar-Tyson, Salisbury GB
Patent application number | Description | Published |
---|---|---|
20090220548 | Immunogenic Agents Against Burkholderia Psudomallei And/Or Burkholderia Mallei, Comprising Lipopolysaccharide, Capsular Polysaccharide And/Or Proteins From Burkholderia Pseudomallei - An immunogenic agent which comprises a killed strain of | 09-03-2009 |
20110236423 | IMMUNOGENIC AGENTS AGAINST BURKHOLDERIA PSEUDOMALLEI AND/OR BURKHOLDERIA MALLEI, COMPRISING LIPOPOLYSACCHARIDE, CAPSULAR POLYSACCHARIDE AND/OR PROTEINS FROM BURKHOLDERIA PSEUDOMALLEI - An immunogenic agent which comprises a killed strain of | 09-29-2011 |